In addition, a significant difference was observed between the mean intensity of TYROBP in patients’ PBMCs and breast cancer cell lines [SKBR3 (p = 0.022), MCF7 (p = 0.007)] (Table 2 and Fig. 3a). Here, TYROBP is linked to breast carcinoma.